Kadimastem Shareholders Approved the Merger with NLS Pharmaceutics
February 4, 2025
NLS Pharmaceutics Ltd, a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for rare and complex central nervous system disorders,
